Loading...

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Authors

Showing 4 results for author "Ali Turunc".

Back to authors

Thumbnail for Ribosomal Stoichiometric Reprogramming and Integrated Stress Response Activation Define a Translational Stalling State in DLBCL Non-Responder CAR-T Infusion Products

ABCL - 910

Ribosomal Stoichiometric Reprogramming and Integrated Stress Response Activation Define a Translational Stalling State in DLBCL Non-Responder CAR-T Infusion Products

Ali Turunc

Poster Presenter: Ali Turunc

Thumbnail for Metabolic Autonomy of Cytotoxic Programs Distinguishes Responder from Non-Responder CAR-T Effectors in DLBCL: A Single-Cell Co-Expression Network Analysis

ABCL - 914

Metabolic Autonomy of Cytotoxic Programs Distinguishes Responder from Non-Responder CAR-T Effectors in DLBCL: A Single-Cell Co-Expression Network Analysis

Ali Turunc

Poster Presenter: Ali Turunc

Thumbnail for Outcomes of Ruxolitinib in Adult Patients with Acute Lymphoblastic Leukemia After Allogeneic Hematopoietic Cell Transplantation: A Propensity Score-Matched Real-World Analysis

ALL - 912

Outcomes of Ruxolitinib in Adult Patients with Acute Lymphoblastic Leukemia After Allogeneic Hematopoietic Cell Transplantation: A Propensity Score-Matched Real-World Analysis

Ali Turunc

Poster Presenter: Ali Turunc

Thumbnail for Asciminib vs Dasatinib/Nilotinib as First-Line Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia: A Propensity Score-Matched Analysis of Disease Progression and Safety Outcomes

CML - 913

Asciminib vs Dasatinib/Nilotinib as First-Line Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia: A Propensity Score-Matched Analysis of Disease Progression and Safety Outcomes

Ali Turunc

Poster Presenter: Ali Turunc

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.